1. Quintana-Castanedo L, Recarte-Marín L, Pérez-Jerónimo L, Conde-Montero E, de la Cueva-Dobao P. Ulcerative necrobiosis lipoidica diabeticorum successfully treated with topical sevoflurane and punch grafting. Int Wound J. 2019;16(5):1234-1236. doi:10.1111/iwj.13179
2. Rueda-Martínez JL, Gerónimo-Pardo M, Martínez-Monsalve A, Martínez-Serrano M. Topical sevoflurane and healing of a post-operative surgical site superinfected by multi-drug-resistant Pseudomonas aeruginosa and susceptible Staphylococcus aureus in an immunocompromised patient. Surg Infect (Larchmt). 2014;15(6):843-846. doi:10.1089/sur.2013.079
3. Imbernon-Moya A, Ortiz-de Frutos FJ, Sanjuan-Alvarez M, Portero-Sanchez I, Merinero-Palomares R, Alcazar V. Treatment of chronic venous ulcers with topical sevoflurane: a retrospective clinical study. Br J Anaesth. 2017;119(4):846-847. doi:10.1093/bja/aex269
4. Potocnik I, Novak Jankovic V, Šostaric M, et. al. Antiinflammatory effect of sevoflurane in open lung surgery with one-lung ventilation. Croat Med J. 2014;55(6):628-637. doi:10.3325/cmj.2014.55.628
5. Yu X, Zhang F, Shi J. Effect of sevoflurane treatment on microglia activation, NF-kB and MAPK activities. Immunobiology. 2019;224(5):638-644. doi:10.1016/j.imbio.2019.07.004
6. Yu QB, Li HM, Li LL, Wang SY, Wu YB. Sevoflurane downregulates interleukin-6 and interleukin-8 levels in patients after cardiopulmonary bypass surgery: a meta-analysis. Genet Mol Res. 2015;14(4):19016-19027. doi:10.4238/2015.December.29.9
7. Chhabra S, Chhabra N, Kaur A, Gupta N. Wound healing concepts in clinical practice of OMFS. J Maxillofac Oral Surg. 2017;16(4):403-423. doi: 10.1007/s12663-016-0880-z
8. Imbernón A, Blázquez C, Puebla A, et. al. Chronic venous ulcer treatment with topical sevoflurane. Int Wound J. 2016;13(5):1060-1062. doi:10.1111/iwj.12474
9. Hidalgo-Doniga C, Lopez-Lopez C, Pajero Otero V, et. al. Use of topical sevoflurane in pressure ulcer treatment in a double-lung transplant patient. J Tissue Viability. 2021;30(1):124-127. doi:10.1016/j.jtv.2020.07.003
10. Fernández-Ginés FD, Cortiñas-Sáenz M, Agudo-Ponce D, et. al. Pain reduction of topical sevoflurane vs intravenous opioids in pressure ulcers. Int Wound J. 2020;17(1):83-90. doi:10.1111/iwj.13235
11. Su L, Zheng J, Wang Y, Zhang W, Hu D. Emerging progress on the mechanism and technology in wound repair. Biomed Pharmacother. 2019; 117:109191. doi:10.1016/j.biopha.2019.109191
12. Dámaso Fernández-Ginés F, Cortiñas-Sáenz M, Mateo-Carrasco H, et. al. Efficacy and safety of topical sevoflurane in the treatment of chronic skin ulcers. Am J Health Syst Pharm. 2017;74(9):176-182. doi:10.2146/ajhp 151008
13. Cha MS, Lee HJ, Bae JH, Yang WS, Baik SW. Effects of sevoflurane on wound healing process. Korean J Anesthesiol. 2009;57(1):78-83. doi:10. 4097/kjae.2009.57.1.78
14. Khan J, Noboru N, Young A, Thomas D. Pro and anti-inflammatory cytokine levels (TNF-α, IL-1β, IL-6 and IL-10) in rat model of neuroma. Pathophysiology. 2017;24(3):155-159. doi:10.1016/j.pathophys.2017.04.001
15. Alzoghaibi MA, Al-Oraini AI, Al-Sagheir AI, Zubaidi AM. Temporal expression of IL-1β and IL-10 in rat skin, muscle, small bowel, and colon wounds: a correlative study. J Basic Clin Physiol Pharmacol. 2014;25(2):205-210. doi:10.1515/jbcpp-2013-0073
16. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991; 174(5):1209-1220. doi:10.1084/jem.174.5.1209